1. CCLHD Research Repositories
  2. Research Hub
  3. Haematology
Please use this identifier to cite or link to this item: https://hdl.handle.net/1/1368
Full metadata record
DC FieldValueLanguage
dc.contributor.authorForsyth, Cecily Jen
dc.contributor.otherCremer, P.D.en
dc.contributor.otherTorzillo, P.en
dc.contributor.otherIland, H.J.en
dc.contributor.otherYoung, G.A.en
dc.date.accessioned2019-04-29T04:20:09Zen
dc.date.available2019-04-29T04:20:09Zen
dc.date.issued1996-02en
dc.identifier.citationVolume 17, Issue 2, pp. 291 - 293en
dc.identifier.issn0268-3369en
dc.identifier.urihttps://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/1368en
dc.description.abstractA 29-year-old male underwent allogeneic bone marrow transplantation for progressive multiple myeloma. His post-transplant course was complicated by severe chronic pulmonary graft-versus-host disease (GVHD) resistant to cyclosporin A, corticosteroids and azathioprine. The introduction of thalidomide resulted in a dramatic improvement in his lung function which has been maintained even after cessation of thalidomide. He remains well 40 months after transplantation.en
dc.subjectHaematologyen
dc.subjectHematologyen
dc.subjectImmunologyen
dc.subjectDrug Therapyen
dc.titleThalidomide responsive chronic pulmonary GVHDen
dc.typeJournal Articleen
dc.description.pubmedurihttps://www.ncbi.nlm.nih.gov/pubmed/8640183en
dc.identifier.journaltitleBone Marrow Transplantationen
dc.type.studyortrialCase Series and Case Reportsen
dc.relation.orcidhttps://orcid.org/0000-0002-9108-3088en
dc.originaltypeTexten
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptHaematology-
Appears in Collections:Haematology
Show simple item record

Page view(s)

46
checked on Jan 14, 2025

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.